Hartland & Co »

Aardvark Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $226 39 5.79

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Capital Management
AQR Capital Management
EcoR1 Capital
Adage Capital Partners GP
State Street Corporation
BlackRock
Geode Capital Management
Cantor Fitzgerald, L. P.
Two Sigma Investments
Raymond James Financial
Vanguard Fiduciary Trust
Woodline Partners

View all funds holding Aardvark Therapeutics